Inventor · disambiguated record
Yunhang Guo
Also filed as: GUO YUNHANG
23 granted patents·21 pending applications·176 citations·filing 2014–2025
95Inventor score
Top patents by PatentIndex Score
44 records- 0198US11142528B2Substituted pyrazolo[1,5-a]pyrimidines as Bruton's tyrosine kinase modulatorsBEIGENE SWITZERLAND GMBH·Filed 2020·Granted Oct 12, 2021·14 cites·19 claims
- 0297US11591340B2Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra- hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereofBEIGENE SWITZERLAND GMBH·Filed 2022·Granted Feb 28, 2023·6 cites·27 claims
- 0397US10570139B2Substituted pyrazolo[1,5-a]pyrimidines as Bruton's tyrosine kinase modulatorsBEIGENE LTD·Filed 2018·Granted Feb 25, 2020·24 cites·15 claims
- 0497US10005782B2Substituted pyrazolo[1,5-a]pyrimidines as bruton's tyrosine kinase modulatorsBEIGENE LTD·Filed 2016·Granted Jun 26, 2018·23 cites·21 claims
- 0597US9556188B2Substituted imidazo[1,2-b]pyrazoles as bruton'S tyrosine kinase modulatorsBEIGENE LTD·Filed 2015·Granted Jan 31, 2017·24 cites·15 claims
- 0697US9447106B2Substituted pyrazolo[1,5-a]pyrimidines as bruton's tyrosine kinase modulatorsBEIGENE LTD·Filed 2015·Granted Sep 20, 2016·30 cites·23 claims
- 0796US10927117B2Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereofBEIGENE SWITZERLAND GMBH·Filed 2017·Granted Feb 23, 2021·18 cites·6 claims
- 0895US11814389B2Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereofBEIGENE SWITZERLAND GMBH·Filed 2022·Granted Nov 14, 2023·3 cites·8 claims
- 0992US12077536B2BCL-2 inhibitorsBEIGENE LTD·Filed 2022·Granted Sep 3, 2024·4 cites·23 claims
- 1089US11420968B2Bcl-2 inhibitorsBEIGENE LTD·Filed 2019·Granted Aug 23, 2022·7 cites·39 claims
- 1189US2024409546A1CRYSTALLINE FORM OF (S)-7-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)-4,5,6,7-TETRA-HYDROPYRAZOLO[1,5-a]PYRIMIDINE-3-CARBOXAMIDE, PREPARATION, AND USES THEREOFBEIGENE SWITZERLAND GMBH·Filed 2024·Application pending·0 cites
- 1288US12103931B2Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereofBEIGENE SWITZERLAND GMBH·Filed 2023·Granted Oct 1, 2024·0 cites·16 claims
- 1388US11970500B1Crystalline form of (s)-7-(1-acryloylpiperidin-4-yl)- 2-(4-phenoxyphenyl)-4,5,6,7-tetra- hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereofBEIGENE SWITZERLAND GMBH·Filed 2023·Granted Apr 30, 2024·0 cites·28 claims
- 1488US2025340560A1SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINES AS BRUTON'S TYROSINE KINASE MODULATORSBEIGENE SWITZERLAND GMBH·Filed 2025·Application pending·0 cites
- 1588US2024254128A1SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINES AS BRUTON'S TYROSINE KINASE MODULATORSBEIGENE SWITZERLAND GMBH·Filed 2024·Application pending·0 cites
- 1687US11999743B2Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereofBEIGENE SWITZERLAND GMBH·Filed 2023·Granted Jun 4, 2024·0 cites·27 claims
- 1785US11555038B2Crystalline forms of (S)-7-(1-(but-2-ynoyl)piperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereofBEIGENE LTD·Filed 2018·Granted Jan 17, 2023·7 cites·7 claims
- 1885US10280163B25 or 8-substituted imidazo[1, 5-a] pyridines as indoleamine and/or tryptophane 2, 3-dioxygenasesBEIGENE LTD·Filed 2016·Granted May 7, 2019·5 cites·30 claims
- 1985US2023242542A1COMPOSITIONS COMPRISING (S)-7-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)-4,5,6,7-TETRA-HYDROPYRAZOLO[1,5-a]PYRIMIDINE-3-CARBOXAMIDEBEIGENE SWITZERLAND GMBH·Filed 2023·Application pending·0 cites
- 2084US11851437B2Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereofBEIGENE SWITZERLAND GMBH·Filed 2022·Granted Dec 26, 2023·0 cites·29 claims
- 2184US11701357B2Treatment of B cell cancers using a combination comprising Btk inhibitorsBEIGENE SWITZERLAND GMBH·Filed 2017·Granted Jul 18, 2023·4 cites·19 claims
- 2284US11377449B2BTK inhibitors with improved dual selectivityBEIGENE LTD·Filed 2018·Granted Jul 5, 2022·3 cites·22 claims
- 2383US11884674B2Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra- hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereofBEIGENE SWITZERLAND GMBH·Filed 2022·Granted Jan 30, 2024·0 cites·28 claims
- 2479US10647714B25 or 8-substituted imidazo[1,5-a]pyridines as indoleamine and/or tryptophane 2,3-dioxygenasesBEIGENE LTD·Filed 2019·Granted May 12, 2020·2 cites·29 claims
- 2579US2023013862A1SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINES AS BRUTON'S TYROSINE KINASE MODULATORSBEIGENE SWITZERLAND GMBH·Filed 2021·Application pending·0 cites
- 2678US2024376097A1BCL-2 InhibitorBEIGENE LTD·Filed 2024·Application pending·0 cites
- 2777US11472788B2Benzoimidazoles as selective inhibitors of indoleamine 2,3-dioxygenasesBEIGENE LTD·Filed 2018·Granted Oct 18, 2022·1 cites·7 claims
- 2877US2024376104A1Bcl-2 InhibitorsBEIGENE LTD·Filed 2024·Application pending·0 cites
- 2976US2021130363A1CRYSTALLINE FORM OF (S)-7-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)-4,5,6,7-TETRA-HYDROPYRAZOLO[1,5-a]PYRIMIDINE-3-CARBOXAMIDE, PREPARATION, AND USES THEREOFBEIGENE SWITZERLAND GMBH·Filed 2021·Application pending·0 cites
- 3073US10882856B25 or 8-substituted imidazo [1,5-a] pyridines as selective inhibitors of indoleamine and/or tryptophane 2,3-dioxygenasesBEIGENE LTD·Filed 2017·Granted Jan 5, 2021·1 cites·33 claims
- 3171US12286430B2Bcl-2 inhibitorBEIGENE LTD·Filed 2021·Granted Apr 29, 2025·0 cites·24 claims
- 3269US2023364096A1Use of a combination comprising a btk inhibitor for treating cancersBEIGENE SWITZERLAND GMBH·Filed 2023·Application pending·0 cites
- 3368US2025059199A1Solid forms of a tyk2 inhibitor, method of preparation, and use thereofBEIGENE SWITZERLAND GMBH·Filed 2024·Application pending·0 cites
- 3467US2025270210A1BCL-2 InhibitorBEIGENE LTD·Filed 2025·Application pending·0 cites
- 3566US2025034128A1Bcl-xl inhibitorsBEIGENE LTD·Filed 2024·Application pending·0 cites
- 3666US2025154138A1Small Molecule IL-17A ModulatorsBEIGENE LTD·Filed 2024·Application pending·0 cites
- 3765US2025122152A1KAT6 InhibitorsBEIGENE SWITZERLAND GMBH·Filed 2024·Application pending·0 cites
- 3865US2022298163A1Btk inhibitors with improved dual selectivityBEIGENE LTD·Filed 2022·Application pending·0 cites
- 3956US2024043435A1Tyk-2 inhibitorBEIGENE LTD·Filed 2021·Application pending·0 cites
- 4055US2025073238A1Methods of treating systemic lupus erythematosus using btk inhibitorsBEIGENE SWITZERLAND GMBH·Filed 2021·Application pending·0 cites
- 4154US2015005277A1Protein Kinase Inhibitors and Uses ThereofBEIGENE LTD·Filed 2014·Application pending·0 cites
- 4253US2024317743A1Solid Forms of BCL-2 Inhibitors, Method of Preparation, and Use ThereofBEIGENE LTD·Filed 2024·Application pending·0 cites
- 4351US2025304535A1KAT6 InhibitorsBEIGENE SWITZERLAND GMBH·Filed 2025·Application pending·0 cites
- 4445US2022281876A1Degradation of bruton's tyrosine kinase (btk) by conjugation of btk inhibitors with e3 ligase ligand and methods of useBEIGENE LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yunhang Guo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →